European Urology
Papers 10000
1 page of 1,000 pages (10k results)
#1Michiel S. van der Heijden (NKI-AVL: Netherlands Cancer Institute)H-Index: 28
#2Yohann Loriot (Institut Gustave Roussy)H-Index: 55
Last. Thomas Powles (QMUL: Queen Mary University of London)H-Index: 84
view all 10 authors...
Abstract Atezolizumab is an anti–PD-L1 immune checkpoint inhibitor recommended for the treatment of locally advanced or metastatic urothelial carcinoma (mUC) after prior platinum-containing chemotherapy, regardless of PD-L1 status, among other treatment settings. We conducted a long-term follow-up to the exploratory analysis of overall survival (OS) and safety for the IMvigor211 intent-to-treat (ITT) population. Patients with mUC and disease progression during or following platinum-based chemoth...
1 CitationsSource
#1Henglong Hu (HUST: Huazhong University of Science and Technology)H-Index: 1
1 CitationsSource
#1Arnaud MejeanH-Index: 61
#2Alain Ravaud (University of Bordeaux)H-Index: 77
Last. Laurent GuyH-Index: 26
view all 0 authors...
Abstract null null Background null The CARMENA trial in patients with metastatic renal cell carcinoma (mRCC) demonstrated that treatment with sunitinib alone was noninferior to cytoreductive nephrectomy (CN) followed by sunitinib (nephrectomy–sunitinib). null null null Objective null The objective of this study was to provide updated overall survival (OS) outcomes of CARMENA and assess whether some subgroups may still benefit from upfront CN. null null null Design, setting, and participants null...
#1Andrea Salonia (UniSR: Vita-Salute San Raffaele University)H-Index: 82
#2C. Bettocchi (University of Foggia)H-Index: 1
Last. Murat Gul (Selçuk University)H-Index: 8
view all 0 authors...
Abstract null null Context null The present summary of the European Association of Urology (EAU) guidelines is based on the latest guidelines on male sexual health published in March 2021, with a last comprehensive update in January 2021. null null null Objective null To present a summary of the 2021 version of the EAU guidelines on sexual and reproductive health. null null null Evidence acquisition null A literature review was performed up to January 2021. The guidelines were updated, and a str...
#1Ricardo Leão (UC: University of Coimbra)H-Index: 13
#2Maarten Albersen (Katholieke Universiteit Leuven)H-Index: 26
Last. Robert J. Hamilton (Princess Margaret Cancer Centre)H-Index: 44
view all 0 authors...
Abstract null null Context null Clinical management of testicular germ cell tumours (GCTs) is hampered by low sensitivity and specificity of the biomarkers currently in use. Circulating microRNAs (miRs) might offer the potential to address areas of unmet clinical need. null null null Objective null To systematically evaluate the evidence for clinical applications of serum levels of miR302/367 and miR371-3 in adult testicular GCTs in terms of primary diagnosis, various clinical scenarios, and the...
#1Swayamjeet Satapathy (PGIMER: Post Graduate Institute of Medical Education and Research)H-Index: 3
#2Namrata Das (PGIMER: Post Graduate Institute of Medical Education and Research)
Last. Bhagwant Rai Mittal (PGIMER: Post Graduate Institute of Medical Education and Research)H-Index: 27
view all 0 authors...
#1Vidit Sharma (Mayo Clinic)H-Index: 15
#2R. Jeffrey Karnes (Mayo Clinic)H-Index: 70
#1Girish S. Kulkarni (Princess Margaret Cancer Centre)H-Index: 34
#1Christoph Würnschimmel (UdeM: Université de Montréal)H-Index: 3
Last. Derya TilkiH-Index: 57
view all 0 authors...
The proposed international staging collaboration for cancer of the prostate (STAR-CAP) clinical prognostic system for prostate cancer predicts cancer-specific mortality (CSM) for patients for whom active treatment, such as radical prostatectomy (RP), is planned. Until now, no validation of STAR-CAP has been performed. We retrospectively analyzed data from our institutional database for 19 552 patients treated with RP between 1992 and 2015. We applied the STAR-CAP point assignment criteria to cal...
#1Laura MarandinoH-Index: 10
#2Andrea Necchi (UniSR: Vita-Salute San Raffaele University)H-Index: 13
Top fields of study
Prostate cancer